implanon- etonogestrel implant
organon usa inc. - etonogestrel (unii: 304gth6rnh) (etonogestrel - unii:304gth6rnh) - etonogestrel 68 mg - implanon® is indicated for use by women to prevent pregnancy. implanon should not be used in women who have - known or suspected pregnancy - current or past history of thrombosis or thromboembolic disorders - liver tumors, benign or malignant, or active liver disease - undiagnosed abnormal genital bleeding - known or suspected breast cancer, personal history of breast cancer, or other progestin-sensitive cancer, now or in the past - allergic reaction to any of the components of implanon [see adverse reactions (6)] risk summary implanon is contraindicated during pregnancy because there is no need for pregnancy prevention in a woman who is already pregnant [see contraindications (4)] . epidemiologic studies and meta-analyses have not shown an increased risk of genital or non-genital birth defects (including cardiac anomalies and limb-reduction defects) following maternal exposure to low dose chcs prior to conception or during early pregnancy. no adverse development outcomes were observed in pregnant rats
implanon nxt etonogestrel 68mg subcutaneous implant
organon pharma pty ltd - etonogestrel -
implanon nxt etonogestrel 68mg subcutaneous implant
organon pharma pty ltd - etonogestrel, quantity: 68 mg - implant - excipient ingredients: magnesium stearate; barium sulfate; vinyl acetate; octadecyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate; isododecane; ethylene/vinyl acetate copolymer - contraception (removed and replaced every three years to ensure continued contraceptive efficacy)
implanon nxt implant 68mg
organon singapore pte. ltd. - (core) etonogestrel - implant - 68mg - (core) etonogestrel 68mg
implanon nxt
merck sharp & dohme australia pty ltd - etonogestrel -
implanon
merck sharp & dohme (new zealand) limited - etonogestrel 68mg - subcutaneous implant - 68 mg - active: etonogestrel 68mg
implanon nxt
organon (new zealand) limited - etonogestrel 68mg; ; etonogestrel 68mg - subcutaneous implant - 68 mg - active: etonogestrel 68mg excipient: barium sulfate ethylenevinylacetate copolymer as evatane 10/40 vn4 co polymer active: etonogestrel 68mg excipient: barium sulfate ethylenevinylacetate copolymer magnesium stearate - contraception (removed and replaced every three years to ensure continued contraceptive efficacy).
implanon nxt, 68 mg implant for subdermal use
merck sharp & dohme ireland (human health) limited - etonogestrel - implant - 68 milligram(s) - progestogens; etonogestrel
implanon nxt 68mg/implant
merck sharp & dohme b.v. waarderweg 39, haarlem noord-holland, 2031 bn, netherlands - etonogestrel - implant - etonogestrel 68 milligram(s) - sex hormones and modulators of the genital system
implanon nxt, 68 mg implant for subdermal use
organon pharma (ireland) limited - etonogestrel - implant - 68 milligram(s) - progestogens; etonogestrel